Cancer Cell International (Jan 2024)

Clinical applications and perspectives of circulating tumor DNA in gastric cancer

  • Jing-Han Li,
  • Dan-Ying Zhang,
  • Ji-Min Zhu,
  • Ling Dong

DOI
https://doi.org/10.1186/s12935-024-03209-4
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Gastric cancer remains a leading cause of cancer-related death worldwide, largely due to inadequate screening methods, late diagnosis, and limited treatment options. Liquid biopsy has emerged as a promising non-invasive approach for cancer screening and prognosis by detecting circulating tumor components like circulating tumor DNA (ctDNA) in the blood. Numerous gastric cancer-specific ctDNA biomarkers have now been identified. CtDNA analysis provides insight into genetic and epigenetic alterations in tumors, holding promise for predicting treatment response and prognosis in gastric cancer patients. This review summarizes current research on ctDNA biology and detection technologies, while highlighting clinical applications of ctDNA for gastric cancer diagnosis, prognosis, and guiding treatment decisions. Current challenges and future perspectives for ctDNA analysis are also discussed.

Keywords